Spendsmart Networks 10-Q/A 21 Oct 13 2013 Q2 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Mar. 31, 2013	Oct. 18, 2013
Document And Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	31-Mar-13
Amendment Flag	TRUE
Amendment Description	This Amendment No. 1 hereby amends our Quarterly Report on Form 10-Q/A (the "Amended 10-Q") for the three and six ended March 31, 2013 and 2012, which was originally filed with the Securities and Exchange Commission on May 17, 2013 (the "Original 10-Q"). This Amendment is being filed to include restated financial statements as described in Note 1, "Restatement of previously issued financial statements", of the Notes to the Condensed Consolidated Statements. The condensed consolidated statements are being restated to correct accounting errors as follows:
	On August 19, 2013, after consulting with the Company's Audit Committee, management concluded it had incorrectly calculated its historical volatility for the fiscal years ended September 30, 2012 and 2011. The error also impacted the three and six months ended March 31, 2013 and 2012. The error specifically related to an excel spreadsheet calculation whereby it was calculating a volatility that was significantly higher than it should have been. The historical volatility is a key assumption and driver in determining the valuation of the company's stock based compensation and derivative liabilities. The impact of the change affects the derivative liabilities, changes in fair value of derivative liabilities, and stock based compensation as of and for the three and six months ended March 31, 2013 and 2012.
	As part of the restatement process, the Company also corrected its tables with respect to options and warrants outstanding. While the financial effects of correcting these tables were not significant, such tables were included as part of the restatement.
	In addition, the Company had previously concluded that they did not maintain effective controls over financial reporting relating to the classification and reporting of financial instruments and consequently that deficiency represented a material weakness over financial reporting as of March 31, 2013. The aforementioned error constitutes an additional deficiency and therefore the Company's assessment of internal control over financial reporting as of March 31, 2013 has not changed.
	The following sections of this Amended 10-Q have been amended to reflect the restatement:
	Part I - Item 1 - Financial Statements and Notes to the Consolidated Financial Statements
	Part I - Item 2 - Management's Discussion and Analysis of Financial Condition and Result of Operations
	Part I - Item 4 - Controls and Procedures
	Part II - Item 1-Legal Proceedings
	For the convenience of the reader, this Amended 10-Q sets forth the Company's Original 10-Q/A in its entirety, as amended by, and to reflect the restatement, as described above.  Except as discussed above, the Company has not modified or updated disclosures presented in this Amendment.  Accordingly, this Amendment does not reflect events occurring after the Original 10-Q or modify or update those disclosures affected by subsequent events, except as specifically referenced herein. Information not affected by the restatement is unchanged and reflects the disclosures made at the time of the Filing of the Original 10-Q.
	This Amended 10-Q has been signed as of the date hereof and all certifications of the Company's Chief Executive Officer/Principal Executive Officer and Chief Financial Officer/Chief Accounting Officer and Principal Financial Officer are given as of the date hereof.  Accordingly, this Amended 10-Q should be read in conjunction with the Company's filings with the Securities and Exchange Commission subsequent to the filing of the Original 10-Q, including any amendments to those filings.
Entity Registrant Name	SpendSmart Payments Co
Entity Central Index Key	1062273
Current Fiscal Year End Date	-21
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		10,356,423

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Sep. 30, 2012
Current assets:
Cash and cash equivalents	$2,454,245	$5,509,911
Amounts on deposit with or due from merchant processors	207,536	203,479
Prepaid insurance	97,127	56,010
Total current assets	2,758,908	5,769,400
Property and equipment, net of accumulated depreciation of $46,320 ($44,057 ? September 30, 2012)	6,450	8,713
Other assets	5,700	5,700
Total assets	2,771,058	5,783,813
Current liabilities:
Accounts payable and accrued liabilities	1,014,947	1,161,191
Accrued and deferred personnel compensation	374,621	271,067
Derivative liabilities	317,929	14,345,625
Total current liabilities	1,707,497	15,777,883
Redeemable Series B convertible preferred stock; $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding; liquidation preference of $0 converted to common stock at January 19, 2013 (10,165 shares issued and outstanding at September 30, 2012; liquidation preference of $10,165,000 at September 30, 2012)		8,656,892
Redeemable common stock; $0.001 par value; 0 shares issued and outstanding, and not classified as equity at March 31, 2013 (784,750 shares issued and outstanding, and not classified as equity at September 30, 2012)		1,026,173
Commitments and contingencies
Stockholders' equity (deficiency):
Redeemable common stock; $0.015 par value; 0 shares issued and outstanding, and not classified as equity at March 31, 2013 (784,750 shares issued and outstanding, and not classified as equity at September 30, 2012)
Common stock; $0.015 par value; 300,000,000 shares authorized; 9,261,061 shares issued and outstanding (5,855,313 ? September 30, 2012)	138,917	87,830
Additional paid-in capital	59,945,128	34,252,571
Accumulated deficit	-59,020,484	-54,017,536
Total stockholders' equity (deficiency)	1,063,561	-19,677,135
Total liabilities and stockholders' equity (deficiency)	$2,771,058	$5,783,813

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Property and equipment, accumulated depreciation	$46,320	$44,057
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	9,261,062	5,855,313
Common stock, shares outstanding	9,261,062	5,855,313
Series A Convertible Preferred Stock [Member]
Convertible preferred stock, par value	$0.00	$0.00
Convertible preferred stock, shares authorized	10,000,000	10,000,000
Convertible preferred stock, shares issued	353	353
Convertible preferred stock, shares outstanding	353	353
Redeemable Series B Preferred Stock (not classified as equity) [Member]
Convertible preferred stock, par value	$0.00	$0.00
Convertible preferred stock, shares authorized	10,000,000	10,000,000
Convertible preferred stock, shares issued	0	10,165
Convertible preferred stock, shares outstanding	0	10,165
Convertible preferred stock, liquidation preference	$0	$10,165,000
Redeemable Common Stock (not classified as equity) [Member]
Convertible preferred stock, par value	$0.00	$0.00
Convertible preferred stock, shares issued	0	784,750
Convertible preferred stock, shares outstanding	0	784,750

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Condensed Consolidated Statements of Operations [Abstract]
Revenues	$298,686	$282,339	$546,182	$517,515
Operating expenses:
Selling and marketing	323,677	303,884	4,978,625	1,796,362
Personnel related	3,372,126	1,835,396	7,265,308	3,456,603
Processing	554,822	577,940	942,176	1,489,067
General and administrative	459,102	386,933	773,748	620,948
Total operating expenses	4,709,727	3,104,153	13,959,857	7,362,980
Loss from operations	-4,411,041	-2,821,814	-13,413,675	-6,845,465
Non-operating income (expense):
Interest income	1,132	1,161	2,176	2,611
Change in fair value of derivative liabilities	-178,739	934,872	8,408,551	1,454,343
Total nonoperating expenses	-177,607	936,033	8,410,727	1,456,954
Net loss and comprehensive net loss	-4,588,648	-1,885,781	-5,002,948	-5,388,511
Deemed dividend on preferred stock		137,802		137,802
Net loss and comprehensive net loss applicable to common shareholders	($4,588,648)	($2,023,583)	($5,002,948)	($5,526,313)
Basic and diluted net loss per share	($0.59)	($0.31)	($0.70)	($0.93)
Basic and diluted weighted average number of common shares outstanding used in computing basic and diluted net loss per share	7,768,072	6,505,248	7,166,097	5,952,662

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Deficiency and Redeemable Preferred and Common Stock (not classified as equity) (USD $)	Total	Redeemable Series B Preferred Stock (not classified as equity) [Member]	Redeemable Common Stock (not classified as equity) [Member]	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Balance at Sep. 30, 2012	($19,677,135)	$8,656,892	$1,026,173		$87,830	$34,252,571	($54,017,536)
Balance, shares at Sep. 30, 2012		10,165	784,750	353	5,855,313
Issuance of common stock and warrants for cash, less issuance costs
Issuance of common stock and warrants for cash, less issuance costs, shares
Issuance of redeemable common and preferred stock and warrants for cash, less issuance costs			4,866,192
Issuance of redeemable common and preferred stock and warrants for cash, less issuance costs, shares	914,665		914,665
Allocation of net proceeds to warrant derivative liability			-3,114,932
Conversions of preferred stock to common stock
Conversions of preferred stock to common stock, shares
Issuance of common stock for services	67,002				168	66,834
Issuance of common stock for services, shares					11,167
Common Shares (reclassify from convertible common stock)	2,777,433		-2,777,433		25,491	2,751,942
Common Shares (reclassify from convertible common stock), shares	1,699,415		-1,699,415		1,699,415
Series B (reclassify from convertible preferred stock)	8,656,892	-8,656,892			25,413	8,631,479
Series B (reclassify from convertible preferred stock), shares		-10,165			1,684,167
Stock based compensation from stock options and warrants	5,499,232					5,499,232
Preferred stock deemed dividend
Repurchase of common stock
Repurchase of common stock, shares
Exercise of warrants to purchase common stock	9,000				15	8,985
Exercise of warrants to purchase common stock, shares					1,000
Forfeiture of accrued compensation
Reclassification of derivative liabilities	8,734,085					8,734,085
Net loss	-5,002,948						-5,002,948
Balance at Mar. 31, 2013	$1,063,561				$138,917	$59,945,128	($59,020,484)
Balance, shares at Mar. 31, 2013				353	9,261,062

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net loss	($5,002,948)	($5,388,511)
Adjustments to reconcile net loss cash flows from operating activities:
Depreciation expense	2,263
Stock based compensation	5,499,232	2,336,469
Issuance of common stock for services	67,002	289,198
Change in fair value of derivative liabilities	-8,408,551	-1,454,343
Changes in operating assets and liabilities:
Prepaid insurance	-41,117	33,500
Amounts on deposit with or due from merchant processors	-4,057	-183,484
Accounts payable and accrued liabilities	-146,237	-963,210
Accrued and deferred personnel compensation	103,555	-187,301
Cash flows used in operating activities	-7,930,858	-5,517,682
Cash flows from financing activities:
Proceeds from issuance of common stock and warrants, net	4,866,192	4,814,923
Exercise of warrants to purchase common stock	9,000
Cash flows from financing activities	4,875,192	4,814,923
Change in cash and cash equivalents	-3,055,666	-702,759
Cash and cash equivalents, beginning of period	5,509,911	1,386,402
Cash and cash equivalents, end of period	$2,454,245	$683,643

Restatement_of_previously_issu

Restatement of previously issued financial statements	6 Months Ended
	Mar. 31, 2013
Restatement of previously issued financial statements [Abstract]
Restatement of previously issued financial statements	1	Restatement of previously issued financial statements
	On August 19, 2013, after consulting with the Company's Audit Committee, management concluded it had incorrectly calculated its historical volatility for the years ended September 30, 2012 and 2011. Those errors also impacted the March 31, 2013 and 2012 interim periods. The error specifically related to an excel spreadsheet calculation whereby it was calculating a volatility that was significantly higher than it should have been. The historical volatility is a key assumption and driver in determining the valuation of the company's stock based compensation and derivative liabilities. The impact of the change affected the derivative liabilities, changes in fair value of derivative liabilities, and stock based compensation as of and for the three and six months ended March 31, 2013 and 2012.
	As part of the restatement process, the Company also corrected its tables with respect to options and warrants outstanding. The financial effects of correcting these tables were not significant, however were included as part of the restatement.
	The following tables summarize the effects of the restatements on the specific items presented in the Company's historical consolidated financial statements previously included in the Company's annual report on Form 10-K for the fiscal year ended September 30, 2012, as amended:
	Consolidated Statement of Operations
	For the three and six months ended March 31, 2012
			For the three months ended March 31, 2012									For the six months ended March 31, 2012
			As Previously Reported			Adjustments			As Restated			As Previously Reported			Adjustments			As Restated
	Personnel related		$	2,249,495			(414,099	)		1,835,396			4,204,623			(748,020	)		3,456,603
	Total operating expenses		$	3,518,252			(414,099	)		3,104,153			8,111,000			(748,020	)		7,362,980
	Loss from operations		$	(3,235,913	)		414,099			(2,821,814	)		(7,593,485	)		748,020			(6,845,465	)
	Change in fair value of derivative liabilities		$	73,146			861,726			934,872			178,813			1,275,530			1,454,343
	Net loss and comprehensive net loss		$	(3,161,606	)		1,275,825			(1,885,781	)		(7,412,061	)		2,023,550			(5,388,511	)
	Deemed dividend on preferred stock		$	-			(137,802	)		(137,802	)		-			(137,802	)		(137,802	)
	Net loss and comprehensive net loss applicable to common shareholders		$	(3,161,606	)		1,138,023			(2,023,583	)		(7,412,061	)		1,885,748			(5,526,313	)
	Basic and diluted net loss per share		$	(0.50	)		0.19			(0.31	)		(1.25	)		0.32			(0.93	)
	Consolidated Statement of Cash Flows
	For the six months ended March 31, 2012
			For the six months ended March 31, 2012
			As Previously Reported			Adjustments			As Restated
	Net loss		$	(7,412,061	)		2,023,550			(5,388,511	)
	Stock based compensation		$	3,084,489			(748,020	)		2,336,469
	Change in fair value of derivative liabilities		$	178,813			1,275,530			1,454,343
	Consolidated Balance Sheet
	For the six months ended March 31, 2013
			For the six months ended March 31, 2013
			As Previously			Adjustments			As Restated
			Reported
	Derivative liabilities		$	433,727			(115,798	)		317,929
	Total current liabilities		$	1,823,295			(115,798	)		1,707,497
	Additional paid-in capital		$	66,579,624			(6,634,496	)		59,945,128
	Accumulated deficit		$	(65,770,778	)		6,750,294			(59,020,484	)
	Total stockholders' equity (deficiency)		$	947,763			115,798			1,063,561
	Consolidated Statement of Operations
	For the three and six months ended March 31, 2013
			For the three months ended March 31, 2013									For the six months ended March 31, 2013
			As Previously			Adjustments			As Restated			As Previously			Adjustments			As Restated
			Reported									Reported on
												Form 10-Q
	Personnel related		$	4,070,580			(698,454	)		3,372,126			9,482,937			(2,217,629	)		7,265,308
	Total operating expenses		$	5,408,181			(698,454	)		4,709,727			16,177,486			(2,217,629	)		13,959,857
	Loss from operations		$	(5,109,495	)		698,454			(4,411,041	)		(15,631,304	)		2,217,629			(13,413,675	)
	Change in fair value of derivative liabilities		$	(319,044	)		140,305			(178,739	)		9,068,880			(660,329	)		8,408,551
	Net loss and comprehensive net loss		$	(5,427,407	)		838,759			(4,588,648	)		(6,560,248	)		1,557,300			(5,002,948	)
	Basic and diluted net loss per share		$	(0.70	)		0.11			(0.59	)		(0.92	)		0.22			(0.70	)
	Consolidated Statement of Cash Flows
	For the six months ended March 31, 2013
			For the six months ended March 31, 2013
			As Previously			Adjustments			As Restated
			Reported
	Net loss		$	(6,560,248	)		1,557,300			(5,002,948	)
	Stock based compensation		$	7,716,861			(2,217,629	)		5,499,232
	Change in fair value of derivative liabilities		$	(9,068,880	)		660,329			(8,408,551	)

Reverse_Stock_Split

Reverse Stock Split	6 Months Ended
	Mar. 31, 2013
Reverse Stock Split [Abstract]
Reverse Stock Split		2	Reverse Stock Split
	On February 13, 2013, the Shareholders of SpendSmart Payments Company (hereinafter referred to as "we" or "the/our Company") authorized its Board of Directors to effect a reverse stock split of all outstanding shares of common stock, warrants and options. The Board of Directors subsequently approved the implementation of a reverse stock split at a ratio of fifteen to one shares, which became effective on April 25, 2013. All share and per share data in these condensed consolidated financial statements and related notes hereto have been retroactively adjusted to the account for the effect of the reverse stock split for the three and six month periods ended March 31, 2013 and 2012, respectively and the balance sheet at September 30, 2012.

Basis_of_Presentation

Basis of Presentation	6 Months Ended
	Mar. 31, 2013
Basis of Presentation [Abstract]
Basis of Presentation		3	Basis of Presentation
	The Company is a Colorado corporation. Through our subsidiary incorporated in the state of California, The SpendSmart Payments Company ("SpendSmart-CA"), we issue and service prepaid cards marketed to young people and their parents. We are a publicly traded company trading on the OTC Bulletin Board under the symbol "SSPC." The accompanying unaudited condensed consolidated financial statements include the accounts of our Company and SpendSmart-CA as of and through March 31, 2013. All intercompany amounts have been eliminated in consolidation.
	We have prepared the accompanying unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with rules and regulations of the United States Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and disclosures required by generally accepted accounting principles for complete financial statements. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. Operating results for the three and six months ended March 31, 2013 are not necessarily indicative of the results that may be expected for the entire year. For further information, see our consolidated financial statements and related disclosures thereto for the year ended September 30, 2012 in our Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on October 7, 2013.
	For the year ended September 30, 2012, our audited consolidated financial statements included an opinion containing an explanatory paragraph as to the uncertainty of our Company's ability to continue as a going concern. Additionally, we have incurred net losses through March 31, 2013 and have yet to establish profitable operations. These factors among others create a substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements as of and for the three and six months ended March 31, 2013 do not contain any adjustments for this uncertainty.  In response to our Company's cash needs, in the first quarter of fiscal 2013 we raised additional cash through the sale of common stock and warrants as described in our footnotes that follow. All additional amounts raised will be used for our future investing and operating cash flow needs.
	We also currently plan to attempt to raise additional required capital through the sale of unregistered shares of our Company's preferred or common stock (accompanied by warrants to purchase our common stock). All additional amounts raised will be used for our future investing and operating cash flow needs. However there can be no assurance that we will be successful in consummating such financing. This description of our recent financing and future plans for financing does not constitute an offer to sell or the solicitation of an offer to buy our securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from the registration requirements and certificates evidencing such shares contain a legend stating the same.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies		4	Summary of Significant Accounting Policies
	Our condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, fair value of financial instruments, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could materially differ from those estimates.
	Revenue Recognition
	We generally have two revenue sources: monthly account fees and usage fees. Monthly account fees are recognized in the month for which the cardholder has a balance on an active card. No fees are charged or recorded as revenue for cards for which there is no cardholder balance. Usage fees are recognized at the time of the transaction. We defer revenue for monthly fees paid in advance of the related month of service. Deferred revenues at March 31, 2013 and September 30, 2012 were insignificant. We recognize fee revenue gross of related processing costs and service fees. We do not collect sales taxes in connection with our products or services. During the six months ended March 31, 2013 we remitted cardholder funds to the issuing bank within two business days of card loading. As of March 31, 2013 and September 30, 2012 we had $207,536 and $203,479, respectively, of cardholder funds included in amounts on deposit with or due from merchant processor and also recorded an offsetting liability of the same amount in accounts payable.
	Cash and cash equivalents
	We consider all investments with an original maturity of three months or less to be cash equivalents. Cash equivalents primarily represent funds invested in money market funds, bank certificates of deposit and U.S. government debt securities whose cost equals fair market value.
	Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances.
	Property and Equipment
	Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the related assets (generally three to five years).  Costs incurred for maintenance and repairs are expensed as incurred and expenditures for major replacements and improvements are capitalized and depreciated over their estimated remaining useful lives.  Depreciation expense for the three and six months ended March 31, 2013 totaled $1,131 and $2,263, respectively (for the three and six months ended March 31, 2012, there was no depreciation expense).
	Valuation of Long-Lived Assets
	We record impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the estimated fair value of the assets. No impairment expense was recorded for the three and six months ended March 31, 2013 or March 31, 2012.
	Income Tax Expense Estimates and Policies
	As part of the income tax provision process of preparing our financial statements, we are required to estimate our Company's provision for income taxes.  This process involves estimating our current tax liabilities together with assessing temporary differences resulting from differing treatments of items for tax and accounting purposes.  These differences result in deferred tax assets and liabilities. Management then assesses the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent believed that recovery is not likely, a valuation allowance is established.  Further, to the extent a valuation allowance is established and changes occur to this allowance in a financial accounting period, such changes are recognized in our tax provision in our consolidated statement of operations.  We use our judgment in making estimates to determine our provision for income taxes, deferred tax assets and liabilities and any valuation allowance is recorded against our net deferred tax assets.
	There are various factors that may cause these tax assumptions to change in the near term, requiring us to write down deferred tax assets or establish tax reserves.  We recognize the benefit of an uncertain tax position taken or expected to be taken on our income tax returns if it is "more likely than not" that such tax position will be sustained based on its technical merits.
	Stock Based Compensation
	We have historically accounted for stock based compensation arrangements through the measurement and recognition of compensation expense for all stock based payment awards to employees and directors based on estimated fair values.  We use the Black-Scholes option valuation model to estimate the fair value of our stock options and warrants at the date of grant.  The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of options and warrants.  We use historical company data among other information to estimate the expected price volatility and the expected forfeiture rate.
	Derivatives
	We account for certain of our outstanding warrants issued in fiscal 2010, 2012 and 2013 ("2010 Warrants," "2012 Warrants" and "2013 Warrants, respectively) as derivative liabilities. The 2010 Warrants were determined to be ineligible for equity classification due to provisions of the respective instruments that may result in an adjustment to their conversion or exercise prices. These derivative liabilities which arose from the issuance of the 2010 Warrants resulted in an ending balance of derivative liabilities of $317,929 and $1,015,284 as of March 31, 2013 and September 30, 2012, respectively. On March 20, 2013, the Company amended its warrant agreement for the 2012 and 2013 warrants whereby removing all terms that required net cash settlement, and as a result, the Company recorded its derivative liabilities relating to these warrants through March 20, 2013, at which time the balance of the derivative liability was reclassified into additional paid in capital. The value of the derivative liability that was reclassified to additional paid in capital at March 20, 2013 was $8,734,085.
	Fair value of assets and liabilities
	Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value for applicable assets and liabilities, we consider the principal or most advantageous market in which we would transact and we consider assumptions market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. This guidance also establishes a fair value hierarchy to prioritize inputs used in measuring fair value as follows:
		·	Level 1: Observable inputs such as quoted prices in active markets;
		·	Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
		·	Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
	Our financial instruments are cash and cash equivalents, accounts payable, and derivative liabilities. The recorded values of cash equivalents and accounts payable approximate their fair values based on their short-term nature. The fair value of derivative liabilities is estimated using option pricing models that are based on the individual characteristics of our warrants, preferred and common stock, the derivative liability on the valuation date as well as assumptions for volatility, remaining expected life, risk-free interest rate and, in some cases, credit spread. The derivative liabilities are the only Level 3 fair value measures.
	These derivative liabilities are remeasured to estimated fair value at March 31, 2013 and September 30, 2012, using the Black-Scholes option pricing model using the following assumptions: contractual life according to the remaining terms of the warrants, no dividend yield, weighed average risk-free interest rate of 0.69% and 0.29% at March 31, 2013 and September 30, 2012, respectively, and weighted average volatility of 75.5% and 72.7% at March 31, 2013 and September 30, 2012, respectively.
	At March 31, 2013 and September 30, 2012, the estimated fair values of the liabilities measured on a recurring basis are as follows:
			Fair Value Measurements at March 31, 2013
			Balance at			Quoted Prices in		Significant Other		Significant Unobservable
			31-Mar-13			Active Markets		Observable Inputs		Inputs (Level 3)
						(Level 1)		(Level 2)
	Warrant derivative liabilities		$	317,929		$	-	$	-	$	317,929
	Total		$	317,929		$	-	$	-	$	317,929
			Fair Value Measurements at September 30, 2012
			Balance at			Quoted Prices in		Significant Other		Significant Unobservable
			September 30,			Active Markets		Observable Inputs		Inputs (Level 3)
			2012			(Level 1)		(Level 2)
	Warrant derivative liabilities		$	14,345,625		$	-	$	-	$	14,345,625
	Total		$	14,345,625		$	-	$	-	$	14,345,625
	The following tables present the activity for liabilities measured at estimated fair value using unobservable inputs for the six months ended March 31, 2013:
			Fair Value Measurements Using Significant Unobservable Inputs
			(Level 3)
			Warrant Derivative
			Liabilities
	Beginning balance at October 1, 2012		$	14,345,625
	Issuance of warrants with derivative liabilities			3,114,940
	Changes in estimated fair value			(8,408,551	)
	Reclassification of derivative liability to additional paid in capital			(8,734,085	)
	Ending balance at March 31, 2013		$	317,929
	Net Loss per Share
	We calculate basic earnings per share ("EPS") by dividing our net income or loss by the weighted average number of common shares outstanding for the period, without considering common stock equivalents.  Diluted EPS is computed by dividing net income or net loss by the weighted average number of common shares outstanding for the period and the weighted average number of dilutive common stock equivalents, such as options and warrants.  Options and warrants are only included in the calculation of diluted EPS when their effect is dilutive.
	Advertising
	We expense advertising costs as incurred.  We have no existing arrangements under which we provide or receive advertising services from others for any consideration other than cash.  On-air advertising expenses totaled $0 and $305,516 for the three and six months ended March 31, 2013, respectively ($106,029 and $1,244,405 during the three and six months ended March 31, 2012, respectively).
	Litigation
	From time to time, we may become involved in disputes, litigation and other legal actions.  We estimate the range of liability related to any pending litigation where the amount and range of loss can be estimated.  We record our best estimate of a loss when the loss is considered probable.  Where a liability is probable and there is a range of estimated loss with no best estimate in the range, we record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. As of the date of this quarterly report we are currently not involved in any significant disputes, litigation and other legal actions.
	Recently Issued Accounting Pronouncements
	In June 2011, the Financial Accounting Standards Board, "FASB" issued ASU 2011-05, "Presentation of Comprehensive Income", an amendment to FASB ASC Topic 220, "Comprehensive Income". The update gives companies the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The amendments in the update do not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income. The ASU is effective for the Company for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of ASU 2011-05 did not have any impact on the company as the company has no other comprehensive income or loss, and therefore the net income or loss equals to the total comprehensive income or loss. In December 2011, the FASB issued ASU 2011-12 "Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05." This update stated that the specific requirement to present items that are reclassified from other comprehensive income to net income alongside their respective components of net income and other comprehensive income will be deferred. In February 2013, the FASB issued ASU 2013-02 "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income". This update requires companies to present the effects on the line items of net income of significant reclassifications out of accumulated other comprehensive income if the amount being reclassified is required under U.S. generally accepted accounting principles to be reclassified in its entirety to net income in the same reporting period.  ASU 2013-02 is effective prospectively for the Company for fiscal years, and interim periods within those years, beginning after December 15, 2012. The Company's condensed consolidated financial statements were not significantly impacted by the adoption of this amended guidance.

Issuances_of_common_stock_and_

Issuances of common stock and warrants	6 Months Ended
	Mar. 31, 2013
Issuances of common stock and warrants [Abstract]
Issuance of common stock and warrants		5	Issuances of common stock and warrants
	During the three and six months ended March 31, 2013, we issued 4,000 and 11,167 shares of our common stock (in each respective period) to a contractor and two vendors in exchange for programming services and other services performed. In connection with these issuances of shares, we recognized expenses of $24,000 and $67,000 during the respective periods.
	During the three and six months ended March 31, 2013 and 2012, we entered into 0 and 63 subscription agreements with accredited investors for 914,665 shares.
	The common stock and related warrants are subject to certain registration rights. Prior to amending the registration rights agreement in March 2013, the 2012 and 2013 Warrants contained a cashless exercise option (the "Penalty"). Despite the Penalty, the registration rights agreements did not include certain prescribed liquidating damage penalties in the event our Company failed to cause the related registration statement to be declared effective and consequently, the presumption under GAAP was that the common stock and related warrants may be settled in cash. Therefore the common stock was classified as redeemable common stock, outside of equity as of September 30, 2012. In addition, the 2012 and 2011 Warrants were also included in derivative liabilities as of September 30, 2012. On March 20, 2013, the Company amended its warrant and registration rights agreement whereby removing all terms that required net cash settlement. As of March 31, 2013, the 1,699,415 shares of common stock of $1,034,281 and related 2012 and 2013 warrants of $14,465,635 are classified as equity and are not reported as derivative liabilities.
	During the six months ended March 31, 2012, the Company issued Series B preferred stock with warrants to purchase additional common stock. The fair value of the warrants issued was approximately $137,802 at the issue date, resulting in a beneficial conversion feature and an immediate deemed dividend of approximately $137,802.

Convertible_Preferred_Stock

Convertible Preferred Stock	6 Months Ended
	Mar. 31, 2013
Convertible Preferred Stock [Abstract]
Convertible Preferred Stock	6	Convertible Preferred Stock
	Series A Preferred Stock
	At March 31, 2013 and September 30, 2012 we had 353 shares of Series A Cumulative Convertible Preferred Stock (the "Series A Stock") outstanding. The Series A Stock was originally issued to investors for $100 per share. The following summarizes the terms of the Series A preferred stock outstanding:
	Face Value:  Each share of Series A Stock has a face and par value of $100 and $.001 per share, respectively.
	Voluntary Conversion:  Each share of Series A Stock is convertible at the election of the holders at any time into approximately 20 shares of our common stock, subject to increase under the anti-dilution provisions under the Certificate of Designation and the Subscription Agreement upon the occurrence of events as defined therein.
	Dividends:  Except in the event of default under the terms of the Subscription Agreement, the Series A Stock pays no dividends.  In the event of an uncured default by our Company, the Series A Stock pays dividends of 12% per annum during the period our Company is in default as described under the Certificate of Designation.
	Redemption:  The Series A Stock is not required to be redeemed by our Company.
	Liquidation Rights:  Upon the occurrence of a liquidation event (as defined in the Certificate of Designation), the holders of Series A Stock will be repaid their full face value and cumulative accrued dividends prior to the receipt of any other class of preferred or common stock.
	Forced Conversion:  We have the right to force conversion of each share of Series A Stock into approximately 20 shares of common stock at any time provided our common stock has maintained a closing price of $15.00 per share for three consecutive trading days prior to conversion.
	Voting Rights: Our Series A Stock has no voting rights.
	Covenants: The Subscription Agreement imposes certain covenants on us, including restrictions against incurring additional indebtedness, issuing any additional equity except certain permitted issuances, creating any liens on our property, amending our certificate of incorporation or bylaws in a manner which may adversely affect the Series A Stock holders, redeeming or paying dividends on shares of our outstanding common stock, and entering into certain related party transactions.
	At March 31, 2013 and September 30, 2012, the Series A preferred stock was convertible into 7,121 shares of our common stock at an effective price of $4.95 per share.
	Series B Preferred Stock
	Our Series B Convertible Preferred Stock ("Series B Stock") automatically converted to common stock on January 19, 2013 as in accordance with the registration statement which states that six months from the date of the final closing, as defined in the related subscription agreement, each share of Series B will automatically convert into common stock. 10,165 outstanding shares of Series B Stock automatically converted into 1,694,167 common shares at an effective price of $600 per share.
	At September 30, 2012 we had 10,165 shares of Series B convertible preferred stock ("Series B Stock") outstanding that were issued to investors for $1,000 per share. The following summarizes the terms of the Series B Stock outstanding:
	Face Value: Each share of Series B Stock has a face and par value of $1,000 and $0.001 per share, respectively.
	Voluntary Conversion: Each share of Series B Stock is convertible at the election of the holders at any time into 167 shares of our common stock. Dividends: None.
	Redemption: The Series B Stock is not required to be redeemed by our Company.
	Liquidation Rights: Upon the occurrence of a liquidation event and after any payments to the holders of Series A Stock, the holders of Series B Stock will be repaid their full face value prior to the receipt of any other class of preferred or common stock.
	Forced Conversion: Each share of Series B Stock shall automatically convert into common stock at the earlier of: 1) the effective date of registration of common shares into which Series B Stock is convertible; or 2) six months from the date of the final closing as defined in the related subscription agreement. The Series B Stock automatically converted to common stock on January 19, 2013 due to (2) above (the final closing date was July 19, 2012).
	Voting Rights: Equal to the largest number of full shares of common stock into which the shares can be converted.

Agreements_for_services_office

Agreements for services, officer and Board of Directors' compensation	6 Months Ended
	Mar. 31, 2013
Agreements for services, officer and Board of Directors' compensation [Abstract]
Agreements for services		7	Agreements for services, officer and Board of Directors' compensation
	In August 2012, we entered into one-year consulting agreements with Patrick Kolenik and Cary Sucoff (Messrs. Kolenik and Sucoff are members of our Company's Board of Directors). The agreements call for the payment to Messrs. Kolenik and Sucoff of $5,000 each per month for their services to our Company. During the three and six months ended March 31, 2013, we recognized and paid expenses totaling $15,000 and $30,000, respectively, each in connection with these consulting agreements.
	In November 2012 (the "Effective Date"), we entered into an Endorsement Agreement (the "Endorsement Agreement") for the promotion of our products. The Endorsement Agreement has a term of fourteen months (the "Term"), unless extended as provided in the Endorsement Agreement. In connection with the Endorsement Agreement, we agreed to pay a nonrefundable advance totaling $3,750,000 (the "Advance"), of which $1,900,000 was paid in November 2012, with the remainder totaling $1,850,000 paid in January 2013. In addition to the Advance, we have agreed to pay monthly incentive compensation per active account ("Incentive Compensation"). The Advance is not recoupable from incentive compensation payments. We also agreed to pay a per month royalty per active account ("Royalty"). The Royalty payments are a single digit percentage of the revenue per card. The Advance is recoupable from Royalty payments made under the Endorsement Agreement. Upon the expiration of the Endorsement Agreement, the endorser will be entitled to receive the Royalty payments, subject to the recoupment of the Advance, and the Incentive Compensation, in perpetuity. The entire balance of the Advance totaling $3,750,000 was charged to operations during the three months ended December 31, 2012. The amount of the royalty payments were immaterial at the end of the six months ended March 31, 2013 due to the timing of the start of this program and the number of accounts earned to date as a result of this endorsement.
	Pursuant to the terms of the Endorsement Agreement, we issued the endorser warrants to purchase up to 133,334 shares of our common stock, as follows: 1) warrants to purchase 66,667 shares of our common stock vested upon the Effective Date, and 2) warrants to purchase another 66,667 shares of our common stock shall vest in equal monthly installments during the Term, each exercisable at an exercise price $7.05 per share. We also issued the endorser warrants to purchase up to an additional 133,333 shares of our common stock (the "Additional Warrant"). The Additional Warrant is exercisable for the number of shares of our common stock equal to five times the number of active accounts in effect at the end of the Term, provided there are more than two hundred and fifty thousand active accounts as of the last day of the Term. The Additional Warrant will be exercisable no more rapidly than in equal monthly installments during the six month period immediately following the Term at an exercise price of $7.05 per share. In the event the product of five times the number of active accounts exceeds two million, we will issue the endorser an "End of Term Warrant" for the number of shares in excess of 133,333. The exercise price of the End of Term Warrant shall be the arithmetic mean of the high and low prices of our Company's common stock on the last trading day before the date of the issuance of the End of Term Warrant. If the Endorsement Agreement is extended, which is at the sole discretion of the endorser, the endorser will receive additional warrants to purchase 133,333 shares of our Company's common stock for any such Extension Period (each, an "Extension Warrant"). Extension Warrants will vest equally on a monthly basis and will have an exercise price equal to the mean of the high and low prices of our Company's common stock on the last trading day before the date of issuance of each Extension Warrant. We recognized $150,674 and $454,723 in expense related to the warrants issued to the endorser during the three and six months ended March 31, 2013.
	Payments made in connection with the Advance, Incentive Compensation and Royalty will be recorded as an expense when incurred. Compensation expense related to the warrants, additional warrants, end of term warrants and extension warrants will be recognized based upon actual and expected vesting, of which an insignificant amount has been expensed for the six months ended March 31, 2013.
	In connection with the Endorsement Agreement as of March 31, 2013, we made payments to two entities associated with a member of our Board of Directors, Jesse Itzler. Expenses related to these payments totaled $604,406 during the period.
	During January 2013 (the "Effective Date"), we entered into a Promotion/Endorsement Agreement (the "P/E Agreement") with a term of eighteen (18) months (the "Term"). In connection with the P/E Agreement, we agreed to pay a nonrefundable fee of two hundred and fifty thousand dollars payable in four equal installments, on predetermined dates over the Term.
	In addition to the fee, we have agreed to pay monthly incentive compensation per active account ("Incentive Compensation") and have issued to the endorser additional warrants to purchase our common stock. Should the number of accounts reach a specified level, the endorser will have the opportunity to earn additional warrants equal to five times the number of active accounts at the end of the Term. The Additional Warrant ("Additional Warrant") is exercisable for the number of shares of our common stock equal to five times the number of active accounts in effect at the end of the Term, provided there are more than two hundred and fifty thousand active accounts as of the last day of the Term. The Additional Warrant will be exercisable no more rapidly than in equal monthly installments during the six month period immediately following the Term at an exercise price of $5.70 per share. In the event the product of five times the number of active accounts exceeds two million, we will issue the endorser an "End of Term Warrant" for the number of shares in excess of 133,333. The exercise price of the End of Term Warrant shall be the arithmetic mean of the high and low prices of our Company's common stock on the last trading day before the date of the issuance of the End of Term Warrant. Extension Warrants will vest equally on a monthly basis and will have an exercise price equal to the mean of the high and low prices of our Company's common stock on the last trading day before the date of issuance of each Extension Warrant. The amount of the warrants were immaterial at the end of the six months ended March 31, 2013 due to the timing of the start of our program and the number of accounts earned to date as a result of this endorsement.
	In October 2012, our Company granted a five-year warrant to purchase up to 133,333 shares of common stock to Chris Leong, a member of our Board of Directors. The warrant vests monthly over a period of twelve months; has an exercise price of $6.90 per share; and includes a cashless exercise option. In November 2012, our Company granted warrants to purchase up to 333,333 shares of common stock to William Hernandez, our Company's President and a member of our Board of Directors (as of January 2013). The warrants vest over a period of three years; have an exercise price of $7.355 per share; include a cashless exercise option; and expire five years after the date of grant. The fair value of these warrants on the grant date was $1,210,150 of which $80,677 and $366,949 was recognized as a noncash charge to personnel related expense during the three and six months ended March 31, 2013, respectively.
	In February 2013, our Company granted warrants to purchase up to 200,000 shares of common stock to Kim Petry, our Company's CFO. The warrants vest over a period of three years; have an exercise price of $5.85 per share; include a cashless exercise option; and expire five years after the date of grant. The fair value of these warrants on the grant date was $587,802 of which $81,695 was recognized as a noncash charge to personnel related expense during the three months ended March 31, 2013.

Stockholders_equity

Stockholders' equity	6 Months Ended
	Mar. 31, 2013
Stockholders' equity [Abstract]
Stockholders' equity	8	Stockholders' equity
	As mentioned in Note 1 the Company effected a reverse stock split of all outstanding shares of common stock, warrants and options, which became effective on April 25, 2013. All share and per share data in these condensed consolidated financial statements and related notes hereto have been retroactively adjusted to the account for the effect of the reverse stock split for the three and six month periods ended March 31, 2013 and 2012, respectively and the balance sheet at September 30, 2012.
	Stock options
	On January 8, 2013, our Board of Directors approved the adoption of the SpendSmart Payments Company 2013 Equity Incentive Plan (the "2013 Plan"). The 2013 Plan was approved by the Company's shareholders on February 15, 2013. The 2013 Plan provides for granting of stock-based awards including: incentive stock options, non-statutory stock options, stock bonuses and rights to acquire restricted stock. The total number of shares of common stock that may be issued pursuant to stock awards under the 2013 Plan shall not exceed in the aggregate 3,000,000 shares of the common stock of our Company. On August 4, 2011, our Board of Directors approved the adoption of the SpendSmart Payments Company 2011 Equity Incentive Plan (the "2011 Plan"). The 2011 Plan provides for granting of stock-based awards including: incentive stock options, non-statutory stock options, stock bonuses and rights to acquire restricted stock. The total number of shares of common stock that may be issued pursuant to stock awards under the Plan shall not exceed in the aggregate 1,666,667 shares of the common stock of our Company. We also have a stockholder-approved Plan (the IdeaEdge, Inc. 2007 Equity Incentive Plan - the "2007 Plan", previously approved by our shareholders). The 2007 Plan has similar provisions and purposes as the 2011 Plan. The total number of shares of common stock that may be issued pursuant to stock awards under the 2007 Plan (as amended) shall not exceed in the aggregate 266,667 shares of the common stock of our Company. Upon shareholder approval of the 2013 Plan, our Board has expressed its intentions to issue no more shares under the 2011 and 2007 Plans.
	Through March 31, 2013, we have outstanding and vested a total of 1,805,000 and 1,160,555, respectively, of incentive and nonqualified stock options granted under the Plans, all of which we have estimated will eventually vest. All of the options have terms of five years with expiration dates ranging from April 2013 to November 2017.
	Warrants
	In recompense for services performed on our behalf, we issued warrants to purchase up to 200,000 and 486,667 shares of our common stock during the three and six months ended March 31, 2013, including a five-year warrant to purchase up to 133,333 shares (exercise price of $6.90 per share) to a member of our Board of Directors and a five-year warrant to purchase up to 200,000 shares at $5.85 to our CFO. Our Company issued warrants to purchase up to 1,003,000 shares of our common stock during the three and six months ended March 31, 2012, including five-year warrants to purchase up to 166,667 shares (exercise price of $7.65 per share) to Mr. Blech, five-year warrants to purchase up to 666,667 (exercise price $6.00 per share) to Mr. Desantis, and five year warrants to purchase up to 3,000,000 (exercise price $6.60 per share) to Mr. Proto. Through March 31, 2013, we have issued warrants to purchase up to a total of 20,000 shares of common stock to advisors, consultants and in connection with the purchase of intellectual property. Warrants to purchase up to 26,667 shares of common stock have expired. Warrants to purchase up to 3,905,992 shares of common stock remain outstanding at March 31, 2013, of which 2,351,970 have vested.
	Through March 31, 2013, we have also issued warrants to purchase up to 4,717,276 shares of our common stock to investors (and as compensation to third parties in connection with investments) related to the sale of our common stock, 4,676,872 of which remain outstanding net of exercises, cancellations and expirations (all of which are fully vested).
	The numbers and exercise prices of all options and warrants outstanding at March 31, 2013 are as follows:
				Weighted
				Average
	Shares			Exercise		Expiration
	Outstanding			Price		Fiscal Period
		19,667			9.3	3rd Qtr, 2013
		124,000			7.2	4th Qtr, 2013
		134,445			6.6	1st Qtr, 2014
		42,044			8.25	2nd Qtr, 2014
		60,667			9.6	3rd Qtr, 2014
		35,000			7.65	4th Qtr, 2014
		106,973			7.65	1st Qtr, 2015
		78,100			7.8	2nd Qtr, 2015
		10,600			10.05	3rd Qtr, 2015
		103,918			6.75	4th Qtr, 2015
		695,572			8.1	1st Qtr, 2016
		882,800			7.2	2nd Qtr, 2016
		960,100			6.45	3rd Qtr, 2016
		1,239,958			6.75	4th Qtr, 2016
		697,996			7.95	1st Qtr, 2017
		859,750			6.15	2nd Qtr, 2017
		1,273,600			7.8	3rd Qtr, 2017
		1,992,958			6.75	4th Qtr, 2017
		736,383			7.95	1st Qtr, 2018
		200,000			5.85	2nd Qtr, 2018
		133,333			7.05	1st Qtr, 2023
		10,387,864
	Stock-based compensation
	During the three and six months ended March 31, 2013, we recognized stock-based compensation expense totaling $2,501,729 and $5,499,232, respectively in connection with the issuance of stock options and warrants issued to employees, directors, advisors and consultants (not including shares of stock issued directly for services). For purposes of accounting for stock-based compensation, the fair value of each award is estimated on the date of grant (or performance of the contracted services as appropriate) using the Black-Scholes-Merton option pricing formula. The following weighted average assumptions were utilized for the calculations of newly issued options and warrants during the six months ended March 31, 2013:
	Expected life (in years)		4.33 years
	Weighted average volatility		93.89	%
	Forfeiture rate		0	%
	Risk-free interest rate		0.74	%
	Expected dividend rate		0	%
	At March 31, 2013, the weighted average exercise price of vested options and warrants outstanding (issued in connection with stock-based compensation) is $6.98 per share while the corresponding weighted average remaining contractual period was approximately 42.9 months. As of March 31, 2013, $9,084,508 of total unrecognized compensation expense related to unvested stock-based compensation is expected to be recognized through February 2016.

Income_taxes

Income taxes	6 Months Ended
	Mar. 31, 2013
Income taxes [Abstract]
Income taxes		9	Income taxes
	We currently estimate our Company's book net operating loss carryforwards ("NOL") and deferred tax asset balance total approximately $56,027,000 and $22,579,000, as of March 31, 2013 ($31,000,000 and $12,885,000 as of September 30, 2012). We have recorded a valuation allowance against our entire deferred tax asset balance due to our lack of a history of earnings, the limitations on the use of our NOL as a result of the SpendSmart-CA acquisition and the future expiration of the NOL. These factors give rise to substantial uncertainty as to whether our net deferred tax assets will be realized. As a result of these factors, our utilization of the NOL will likely be severely limited and a substantial portion of the NOL will likely expire unused.

Subsequent_events

Subsequent events	6 Months Ended
	Mar. 31, 2013
Subsequent events [Abstract]
Subsequent events	10	Subsequent Events
	On June 10, 2013, the Company announced its intention to redeem certain classes of outstanding warrants that were initially issued to investors participating in private placement financings in 2010, 2011 and 2012 consisting of the following classes: (i) outstanding warrants to purchase an aggregate of 634,916 shares of the Company's common stock issued to investors participating in the Company's private placement financing completed on December 13, 2012 and November 30, 2012, of which 541,667 are exercisable at an exercise price of $7.50 per share (the "$7.50 December Warrants") and 93,249 are exercisable at an exercise price of $9.00 per share (the "$9.00 December Warrants"); (ii) outstanding warrants to purchase an aggregate of 1,016,518 shares of the Company's common stock issued to investors participating in the Company's private placement financings closed on July 19, 2012, June 20, 2012, May 24, 2012 and March 31, 2012, of which 833,333 are exercisable at an exercise price of $7.50 per share (the "$7.50 Investor Warrants") and 183,185 are exercisable at an exercise price of $9.00 per share (the "$9.00 Investor Warrants"); (iii) outstanding warrants to purchase an aggregate of 446,188 shares of the Company's common stock issued to investors participating in the Company's private placement financing completed on October 21, 2011 and November 21, 2011, of which 333,334 are exercisable at an exercise price of $7.50 per share (the "$7.50 2011 Warrants") and 112,854 are exercisable at an exercise price of $9.00 per share (the "$9.00 2011 Warrants"); and (iv) outstanding warrants to purchase an aggregate of 431,950 shares of the Company's common stock issued to investors participating in the Company's private placement financings closed on November 16, 2010, of which 125,000 are exercisable at an exercise price of $6.00 per share (the "$6.00 2010 Warrants") and 306,950 are exercisable at an exercise price of $9.00 per share (the "$9.00 2010 Warrants").The warrant redemption was intended to raise non-dilutive capital.
	A Notice of Election to Participate was provided to the affected warrant holders on June 10, 2013. These warrant holders had until 5:00 p.m. ET on July 15, 2013, to exercise their outstanding warrants at $2.25 per share. Pursuant to the Offer to Amend and Exercise, on July 15, 2013 an aggregate of 662,540 warrants were tendered by their holders and were amended and exercised in connection therewith for an aggregate exercise price of approximately $1,490,715, including the following warrants: 85,974 $9.00 December Warrants; 99,703 $9.00 Investor Warrants; 83,334 $7.50 Investor Warrants; 82,408 $9.00 2011 Warrants; 93,751 $7.50 2011 Warrants; 154,870 $9.00 2010 Warrants; and 62,500 $6.00 2010 Warrants.
	On October 1, 2013, Jerold Rubinstein was elected as a new board of director and head of the Audit Committee. He received 133,333 warrants with an exercise price of 2.00 per share.
	On October 1, 2013, Brian Thompson resigned as a member of the board and as head of the Audit Committee.
	On October 15, 2013, the Company, through its wholly owned subsidiary The SpendSmart Payments Company, a California corporation, entered into an Asset Purchase Agreement (the "Agreement") with Intellectual Capital Management, Inc., d/b/a SMS Masterminds ("SMS") a Nevada corporation, whereby, upon the completion of certain closing conditions, the Company will purchase substantially all of the assets of SMS.  In consideration for such assets, the Company has agreed to issue SMS an aggregate of five million two hundred and fifty thousand shares of common stock of the Company. The closing of the Agreement is subject to standard and customary closing deliverables and is contingent upon, among other things, the Company completing due diligence of the assets and business of SMS to its sole satisfaction.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policy)	6 Months Ended
	Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, fair value of financial instruments, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could materially differ from those estimates.
Revenue Recognition	Revenue Recognition
	We generally have two revenue sources: monthly account fees and usage fees. Monthly account fees are recognized in the month for which the cardholder has a balance on an active card. No fees are charged or recorded as revenue for cards for which there is no cardholder balance. Usage fees are recognized at the time of the transaction. We defer revenue for monthly fees paid in advance of the related month of service. Deferred revenues at March 31, 2013 and September 30, 2012 were insignificant. We recognize fee revenue gross of related processing costs and service fees. We do not collect sales taxes in connection with our products or services. During the six months ended March 31, 2013 we remitted cardholder funds to the issuing bank within two business days of card loading. As of March 31, 2013 and September 30, 2012 we had $207,536 and $203,479, respectively, of cardholder funds included in amounts on deposit with or due from merchant processor and also recorded an offsetting liability of the same amount in accounts payable.
Cash and cash equivalents	Cash and cash equivalents
	We consider all investments with an original maturity of three months or less to be cash equivalents. Cash equivalents primarily represent funds invested in money market funds, bank certificates of deposit and U.S. government debt securities whose cost equals fair market value.
	Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances.
Property and Equipment	Property and Equipment
	Property and equipment are recorded at cost and depreciated using the straight-line method over the estimated useful lives of the related assets (generally three to five years).  Costs incurred for maintenance and repairs are expensed as incurred and expenditures for major replacements and improvements are capitalized and depreciated over their estimated remaining useful lives.  Depreciation expense for the three and six months ended March 31, 2013 totaled $1,131 and $2,263, respectively (for the three and six months ended March 31, 2012, there was no depreciation expense).
Valuation of Long-Lived Assets	Valuation of Long-Lived Assets
	We record impairment losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amounts of the assets exceed the estimated fair value of the assets. No impairment expense was recorded for the three and six months ended March 31, 2013 or March 31, 2012.
Income Tax Expense Estimates and Policies	Income Tax Expense Estimates and Policies
	As part of the income tax provision process of preparing our financial statements, we are required to estimate our Company's provision for income taxes.  This process involves estimating our current tax liabilities together with assessing temporary differences resulting from differing treatments of items for tax and accounting purposes.  These differences result in deferred tax assets and liabilities. Management then assesses the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent believed that recovery is not likely, a valuation allowance is established.  Further, to the extent a valuation allowance is established and changes occur to this allowance in a financial accounting period, such changes are recognized in our tax provision in our consolidated statement of operations.  We use our judgment in making estimates to determine our provision for income taxes, deferred tax assets and liabilities and any valuation allowance is recorded against our net deferred tax assets.
	There are various factors that may cause these tax assumptions to change in the near term, requiring us to write down deferred tax assets or establish tax reserves.  We recognize the benefit of an uncertain tax position taken or expected to be taken on our income tax returns if it is "more likely than not" that such tax position will be sustained based on its technical merits.
Stock Based Compensation	Stock Based Compensation
	We have historically accounted for stock based compensation arrangements through the measurement and recognition of compensation expense for all stock based payment awards to employees and directors based on estimated fair values.  We use the Black-Scholes option valuation model to estimate the fair value of our stock options and warrants at the date of grant.  The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of options and warrants.  We use historical company data among other information to estimate the expected price volatility and the expected forfeiture rate.
Derivatives	Derivatives
	We account for certain of our outstanding warrants issued in fiscal 2010, 2012 and 2013 ("2010 Warrants," "2012 Warrants" and "2013 Warrants, respectively) as derivative liabilities. The 2010 Warrants were determined to be ineligible for equity classification due to provisions of the respective instruments that may result in an adjustment to their conversion or exercise prices. These derivative liabilities which arose from the issuance of the 2010 Warrants resulted in an ending balance of derivative liabilities of $317,929 and $1,015,284 as of March 31, 2013 and September 30, 2012, respectively. On March 20, 2013, the Company amended its warrant agreement for the 2012 and 2013 warrants whereby removing all terms that required net cash settlement, and as a result, the Company recorded its derivative liabilities relating to these warrants through March 20, 2013, at which time the balance of the derivative liability was reclassified into additional paid in capital. The value of the derivative liability that was reclassified to additional paid in capital at March 20, 2013 was $8,734,085.
Fair value of assets and liabilities	Fair value of assets and liabilities
	Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value for applicable assets and liabilities, we consider the principal or most advantageous market in which we would transact and we consider assumptions market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. This guidance also establishes a fair value hierarchy to prioritize inputs used in measuring fair value as follows:
		·	Level 1: Observable inputs such as quoted prices in active markets;
		·	Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
		·	Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
	Our financial instruments are cash and cash equivalents, accounts payable, and derivative liabilities. The recorded values of cash equivalents and accounts payable approximate their fair values based on their short-term nature. The fair value of derivative liabilities is estimated using option pricing models that are based on the individual characteristics of our warrants, preferred and common stock, the derivative liability on the valuation date as well as assumptions for volatility, remaining expected life, risk-free interest rate and, in some cases, credit spread. The derivative liabilities are the only Level 3 fair value measures.
	These derivative liabilities are remeasured to estimated fair value at March 31, 2013 and September 30, 2012, using the Black-Scholes option pricing model using the following assumptions: contractual life according to the remaining terms of the warrants, no dividend yield, weighed average risk-free interest rate of 0.69% and 0.29% at March 31, 2013 and September 30, 2012, respectively, and weighted average volatility of 75.5% and 72.7% at March 31, 2013 and September 30, 2012, respectively.
	At March 31, 2013 and September 30, 2012, the estimated fair values of the liabilities measured on a recurring basis are as follows:
			Fair Value Measurements at March 31, 2013
			Balance at			Quoted Prices in		Significant Other		Significant Unobservable
			31-Mar-13			Active Markets		Observable Inputs		Inputs (Level 3)
						(Level 1)		(Level 2)
	Warrant derivative liabilities		$	317,929		$	-	$	-	$	317,929
	Total		$	317,929		$	-	$	-	$	317,929
			Fair Value Measurements at September 30, 2012
			Balance at			Quoted Prices in		Significant Other		Significant Unobservable
			September 30,			Active Markets		Observable Inputs		Inputs (Level 3)
			2012			(Level 1)		(Level 2)
	Warrant derivative liabilities		$	14,345,625		$	-	$	-	$	14,345,625
	Total		$	14,345,625		$	-	$	-	$	14,345,625
	The following tables present the activity for liabilities measured at estimated fair value using unobservable inputs for the six months ended March 31, 2013:
			Fair Value Measurements Using Significant Unobservable Inputs
			(Level 3)
			Warrant Derivative
			Liabilities
	Beginning balance at October 1, 2012		$	14,345,625
	Issuance of warrants with derivative liabilities			3,114,940
	Changes in estimated fair value			(8,408,551	)
	Reclassification of derivative liability to additional paid in capital			(8,734,085	)
	Ending balance at March 31, 2013		$	317,929
Net Loss per Share	Net Loss per Share
	We calculate basic earnings per share ("EPS") by dividing our net income or loss by the weighted average number of common shares outstanding for the period, without considering common stock equivalents.  Diluted EPS is computed by dividing net income or net loss by the weighted average number of common shares outstanding for the period and the weighted average number of dilutive common stock equivalents, such as options and warrants.  Options and warrants are only included in the calculation of diluted EPS when their effect is dilutive.
Advertising	Advertising
	We expense advertising costs as incurred.  We have no existing arrangements under which we provide or receive advertising services from others for any consideration other than cash.  On-air advertising expenses totaled $0 and $305,516 for the three and six months ended March 31, 2013, respectively ($106,029 and $1,244,405 during the three and six months ended March 31, 2012, respectively).
Litigation	Litigation
	From time to time, we may become involved in disputes, litigation and other legal actions.  We estimate the range of liability related to any pending litigation where the amount and range of loss can be estimated.  We record our best estimate of a loss when the loss is considered probable.  Where a liability is probable and there is a range of estimated loss with no best estimate in the range, we record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. As of the date of this quarterly report we are currently not involved in any significant disputes, litigation and other legal actions.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements
	In June 2011, the Financial Accounting Standards Board, "FASB" issued ASU 2011-05, "Presentation of Comprehensive Income", an amendment to FASB ASC Topic 220, "Comprehensive Income". The update gives companies the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The amendments in the update do not change the items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to net income. The ASU is effective for the Company for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of ASU 2011-05 did not have any impact on the company as the company has no other comprehensive income or loss, and therefore the net income or loss equals to the total comprehensive income or loss. In December 2011, the FASB issued ASU 2011-12 "Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05." This update stated that the specific requirement to present items that are reclassified from other comprehensive income to net income alongside their respective components of net income and other comprehensive income will be deferred. In February 2013, the FASB issued ASU 2013-02 "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income". This update requires companies to present the effects on the line items of net income of significant reclassifications out of accumulated other comprehensive income if the amount being reclassified is required under U.S. generally accepted accounting principles to be reclassified in its entirety to net income in the same reporting period.  ASU 2013-02 is effective prospectively for the Company for fiscal years, and interim periods within those years, beginning after December 15, 2012. The Company's condensed consolidated financial statements were not significantly impacted by the adoption of this amended guidance.

Restatement_of_previously_issu1

Restatement of previously issued financial statements (Tables)	6 Months Ended
	Mar. 31, 2013
Restatement of previously issued financial statements [Abstract]
Schedule of Restatement of Previously Issued Financial Statements	Consolidated Statement of Operations
	For the three and six months ended March 31, 2012
		For the three months ended March 31, 2012									For the six months ended March 31, 2012
		As Previously Reported			Adjustments			As Restated			As Previously Reported			Adjustments			As Restated
	Personnel related	$	2,249,495			(414,099	)		1,835,396			4,204,623			(748,020	)		3,456,603
	Total operating expenses	$	3,518,252			(414,099	)		3,104,153			8,111,000			(748,020	)		7,362,980
	Loss from operations	$	(3,235,913	)		414,099			(2,821,814	)		(7,593,485	)		748,020			(6,845,465	)
	Change in fair value of derivative liabilities	$	73,146			861,726			934,872			178,813			1,275,530			1,454,343
	Net loss and comprehensive net loss	$	(3,161,606	)		1,275,825			(1,885,781	)		(7,412,061	)		2,023,550			(5,388,511	)
	Deemed dividend on preferred stock	$	-			(137,802	)		(137,802	)		-			(137,802	)		(137,802	)
	Net loss and comprehensive net loss applicable to common shareholders	$	(3,161,606	)		1,138,023			(2,023,583	)		(7,412,061	)		1,885,748			(5,526,313	)
	Basic and diluted net loss per share	$	(0.50	)		0.19			(0.31	)		(1.25	)		0.32			(0.93	)
	Consolidated Statement of Cash Flows
	For the six months ended March 31, 2012
		For the six months ended March 31, 2012
		As Previously Reported			Adjustments			As Restated
	Net loss	$	(7,412,061	)		2,023,550			(5,388,511	)
	Stock based compensation	$	3,084,489			(748,020	)		2,336,469
	Change in fair value of derivative liabilities	$	178,813			1,275,530			1,454,343
	Consolidated Balance Sheet
	For the six months ended March 31, 2013
		For the six months ended March 31, 2013
		As Previously			Adjustments			As Restated
		Reported
	Derivative liabilities	$	433,727			(115,798	)		317,929
	Total current liabilities	$	1,823,295			(115,798	)		1,707,497
	Additional paid-in capital	$	66,579,624			(6,634,496	)		59,945,128
	Accumulated deficit	$	(65,770,778	)		6,750,294			(59,020,484	)
	Total stockholders' equity (deficiency)	$	947,763			115,798			1,063,561
	Consolidated Statement of Operations
	For the three and six months ended March 31, 2013
		For the three months ended March 31, 2013									For the six months ended March 31, 2013
		As Previously			Adjustments			As Restated			As Previously			Adjustments			As Restated
		Reported									Reported on
											Form 10-Q
	Personnel related	$	4,070,580			(698,454	)		3,372,126			9,482,937			(2,217,629	)		7,265,308
	Total operating expenses	$	5,408,181			(698,454	)		4,709,727			16,177,486			(2,217,629	)		13,959,857
	Loss from operations	$	(5,109,495	)		698,454			(4,411,041	)		(15,631,304	)		2,217,629			(13,413,675	)
	Change in fair value of derivative liabilities	$	(319,044	)		140,305			(178,739	)		9,068,880			(660,329	)		8,408,551
	Net loss and comprehensive net loss	$	(5,427,407	)		838,759			(4,588,648	)		(6,560,248	)		1,557,300			(5,002,948	)
	Basic and diluted net loss per share	$	(0.70	)		0.11			(0.59	)		(0.92	)		0.22			(0.70	)
	Consolidated Statement of Cash Flows
	For the six months ended March 31, 2013
		For the six months ended March 31, 2013
		As Previously			Adjustments			As Restated
		Reported
	Net loss	$	(6,560,248	)		1,557,300			(5,002,948	)
	Stock based compensation	$	7,716,861			(2,217,629	)		5,499,232
	Change in fair value of derivative liabilities	$	(9,068,880	)		660,329			(8,408,551	)

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Schedule of Fair Value of the Liabilities Measured on a Recurring Basis	Fair Value Measurements at March 31, 2013
		Balance at			Quoted Prices in		Significant Other		Significant Unobservable
		31-Mar-13			Active Markets		Observable Inputs		Inputs (Level 3)
					(Level 1)		(Level 2)
	Warrant derivative liabilities	$	317,929		$	-	$	-	$	317,929
	Total	$	317,929		$	-	$	-	$	317,929
		Fair Value Measurements at September 30, 2012
		Balance at			Quoted Prices in		Significant Other		Significant Unobservable
		September 30,			Active Markets		Observable Inputs		Inputs (Level 3)
		2012			(Level 1)		(Level 2)
	Warrant derivative liabilities	$	14,345,625		$	-	$	-	$	14,345,625
	Total	$	14,345,625		$	-	$	-	$	14,345,625
Schedule of Activity for Liabilities Measured at Fair Value using Unobservable Inputs	Fair Value Measurements Using Significant Unobservable Inputs
	(Level 3)
		Warrant Derivative
		Liabilities
	Beginning balance at October 1, 2012	$	14,345,625
	Issuance of warrants with derivative liabilities		3,114,940
	Changes in estimated fair value		(8,408,551	)
	Reclassification of derivative liability to additional paid in capital		(8,734,085	)
	Ending balance at March 31, 2013	$	317,929

Stockholders_equity_Tables

Stockholders' equity (Tables)	6 Months Ended
	Mar. 31, 2013
Stockholders' equity [Abstract]
Schedule of Option and Warrant Activity				Weighted
				Average
	Shares			Exercise		Expiration
	Outstanding			Price		Fiscal Period
		19,667			9.3	3rd Qtr, 2013
		124,000			7.2	4th Qtr, 2013
		134,445			6.6	1st Qtr, 2014
		42,044			8.25	2nd Qtr, 2014
		60,667			9.6	3rd Qtr, 2014
		35,000			7.65	4th Qtr, 2014
		106,973			7.65	1st Qtr, 2015
		78,100			7.8	2nd Qtr, 2015
		10,600			10.05	3rd Qtr, 2015
		103,918			6.75	4th Qtr, 2015
		695,572			8.1	1st Qtr, 2016
		882,800			7.2	2nd Qtr, 2016
		960,100			6.45	3rd Qtr, 2016
		1,239,958			6.75	4th Qtr, 2016
		697,996			7.95	1st Qtr, 2017
		859,750			6.15	2nd Qtr, 2017
		1,273,600			7.8	3rd Qtr, 2017
		1,992,958			6.75	4th Qtr, 2017
		736,383			7.95	1st Qtr, 2018
		200,000			5.85	2nd Qtr, 2018
		133,333			7.05	1st Qtr, 2023
		10,387,864
Schedule of Assumptions for Calculations of Newly Issued Options and Warrants	Expected life (in years)		4.33 years
	Weighted average volatility		93.89	%
	Forfeiture rate		0	%
	Risk-free interest rate		0.74	%
	Expected dividend rate		0	%

Restatement_of_previously_issu2

Restatement of previously issued financial statements (Consolidated Balance Sheet) (Details) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Derivative liabilities	$317,929	$14,345,625
Total current liabilities	1,707,497	15,777,883
Additional paid-in capital	59,945,128	34,252,571
Accumulated deficit	-59,020,484	-54,017,536
Total stockholders' equity (deficiency)	1,063,561	-19,677,135
As Previously Reported on Form 10-K [Member]
Derivative liabilities	433,727
Total current liabilities	1,823,295
Additional paid-in capital	66,579,624
Accumulated deficit	-65,770,778
Total stockholders' equity (deficiency)	947,763
Adjustments [Member]
Derivative liabilities	-115,798
Total current liabilities	-115,798
Additional paid-in capital	-6,634,496
Accumulated deficit	6,750,294
Total stockholders' equity (deficiency)	$115,798

Restatement_of_previously_issu3

Restatement of previously issued financial statements (Consolidated Statement of Operations) (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Personnel related	$3,372,126	$1,835,396	$7,265,308	$3,456,603
Total operating expenses	4,709,727	3,104,153	13,959,857	7,362,980
Loss from operations	-4,411,041	-2,821,814	-13,413,675	-6,845,465
Change in fair value of derivative liabilities	-178,739	934,872	8,408,551	1,454,343
Net loss and comprehensive net loss	-4,588,648	-1,885,781	-5,002,948	-5,388,511
Deemed dividend on preferred stock		-137,802		-137,802
Net loss and comprehensive net loss applicable to common shareholders	-4,588,648	-2,023,583	-5,002,948	-5,526,313
Basic and diluted net loss per share	($0.59)	($0.31)	($0.70)	($0.93)
As Previously Reported on Form 10-K [Member]
Personnel related	4,070,580	2,249,495	9,482,937	4,204,623
Total operating expenses	5,408,181	3,518,252	16,177,486	8,111,000
Loss from operations	-5,109,495	-3,235,913	-15,631,304	-7,593,485
Change in fair value of derivative liabilities	-319,044	73,146	9,068,880	178,813
Net loss and comprehensive net loss	-5,427,407	-3,161,606	-6,560,248	-7,412,061
Deemed dividend on preferred stock
Net loss and comprehensive net loss applicable to common shareholders		-3,161,606		-7,412,061
Basic and diluted net loss per share	($0.70)	($0.50)	($0.92)	($1.25)
Adjustments [Member]
Personnel related	-698,454	-414,099	-2,217,629	-748,020
Total operating expenses	-698,454	-414,099	-2,217,629	-748,020
Loss from operations	698,454	414,099	2,217,629	748,020
Change in fair value of derivative liabilities	14,305	861,726	-660,329	1,275,530
Net loss and comprehensive net loss	838,759	1,275,825	1,557,300	2,023,550
Deemed dividend on preferred stock		-137,802		-137,802
Net loss and comprehensive net loss applicable to common shareholders		$1,138,023		$1,885,748
Basic and diluted net loss per share	$0.11	$0.19	$0.22	$0.32

Restatement_of_previously_issu4

Restatement of previously issued financial statements (Consolidated Statement of Cash Flows) (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Net loss	($4,588,648)	($1,885,781)	($5,002,948)	($5,388,511)
Stock based compensation			5,499,232	2,336,469
Change in fair value of derivative liabilities	178,739	-934,872	-8,408,551	-1,454,343
As Previously Reported on Form 10-K [Member]
Net loss	-5,427,407	-3,161,606	-6,560,248	-7,412,061
Stock based compensation			7,716,861	3,084,489
Change in fair value of derivative liabilities	319,044	-73,146	-9,068,880	-178,813
Adjustments [Member]
Net loss	838,759	1,275,825	1,557,300	2,023,550
Stock based compensation			-2,217,629	-748,020
Change in fair value of derivative liabilities	($14,305)	($861,726)	$660,329	($1,275,530)

Reverse_Stock_Split_Details

Reverse Stock Split (Details)	Feb. 13, 2013
Reverse Stock Split [Abstract]
Reverse stock split ratio	15

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012	Sep. 30, 2012
Summary of Significant Accounting Policies [Abstract]
Cardholder funds	$207,536		$207,536		$203,479
Derivative liabilities, 2010 warrants	317,929		317,929		1,015,284
Derivative liabilities reclassified to additional paid-in capital			8,734,085
Advertising expense	0	106,029	305,516	1,244,405
Property, Plant and Equipment [Line Items]
Depreciation expense	$1,131		$2,263
Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life			3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life			5 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Schedule of Fair Values of the Liabilities Measured on a Recurring Basis) (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Mar. 31, 2013	Sep. 30, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant derivative liabilities	$317,929	$14,345,625
Total	317,929	14,345,625
Quoted Prices in Active Markets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant derivative liabilities
Total
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant derivative liabilities
Total
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant derivative liabilities	317,929	14,345,625
Total	$317,929	$14,345,625

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Schedule of Activity for Liabilities Measured at Fair Value using Unobservable Inputs) (Details) (USD $)	6 Months Ended	12 Months Ended
	Mar. 31, 2013	Sep. 30, 2012
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Risk-free interest rate	0.74%
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$14,345,625
Issuance of warrants with derivative liabilities	3,114,940
Changes in estimated fair value	-8,408,551
Reclassification of derivative liability to additional paid in capital	8,734,085
Ending balance	$317,929	$14,345,625
Risk-free interest rate	0.69%	0.29%
Volatility	75.50%	72.70%

Issuances_of_common_stock_and_1

Issuances of common stock and warrants (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Issuance Of Common Stock And Warrants [Line Items]
Shares issued for services	4,000		11,167
Shares issued for services, expense	$24,000		$67,000
Subscription agreements, number of investors	0	0	63	63
Issuance of redeemable common and preferred stock and warrants for cash, less issuance costs, shares			914,665	914,665
Common Shares (reclassify from convertible common stock), shares			1,699,415
Common Shares (reclassify from convertible common stock)			2,777,433
Warrants	14,465,635	137,802	14,465,635	137,802
Deemed dividend on preferred stock		($137,802)		($137,802)

Convertible_Preferred_Stock_De

Convertible Preferred Stock (Details) (USD $)	6 Months Ended	12 Months Ended	3 Months Ended
	Mar. 31, 2013	Sep. 30, 2012	Mar. 31, 2013	Jan. 19, 2013	Sep. 30, 2012
	Series A Preferred Stock [Member]	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series B Preferred Stock [Member]	Series B Preferred Stock [Member]
Convertible preferred stock, shares outstanding	353	353	0		10,165
Convertible preferred stock, face value	$100	$100			$1,000
Convertible preferred stock, par value	$0.00	$0.00	$0.00		$0.00
Number of shares issued for each share of convertible preferred stock	20	20			167
Dividends, per annum percent	12.00%	12.00%
Force conversion, requisite closing price	$15	$15
Force conversion, number of days requisite closing price must be maintained	3	3
Convertible preferred stock, total number of shares of common stock	7,121	7,121
Convertible preferred stock, effective price per share	$4.95	$4.95		$600
Conversion, preferred shares converted			10,165
Conversion, common shares issued			1,694,167

Agreements_for_services_office1

Agreements for services, officer and Board of Directors' compensation (Details) (USD $)

1 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

3 Months Ended

Jan. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Jan. 31, 2013

Nov. 30, 2012

Mar. 31, 2013

Mar. 31, 2013

Nov. 30, 2012

Nov. 30, 2012

Nov. 30, 2012

Nov. 30, 2012

Mar. 31, 2013

Oct. 31, 2012

Nov. 30, 2012

Mar. 31, 2013

Mar. 31, 2013

Feb. 28, 2013

Mar. 31, 2013

Mr. Kolenik [Member]

Mr. Kolenik [Member]

Mr. Sucoff [Member]

Mr. Sucoff [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Endorsement Agreement [Member]

Jesse Itzler [Member]

Chris Leong [Member]

William Hernandez [Member]

Board of Directors [Member]

Board of Directors [Member]

Kim Petry [Member]

Kim Petry [Member]

Vesting Immediately [Member]

Extension Warrant [Member]

Vesting Monthly [Member]

Additional Warrant [Member]

Investor Related Services [Line Items]

Monthly payment for investor relation services

$5,000

$5,000

$5,000

$5,000

Professional expense

15,000

30,000

15,000

30,000

Warrants

14,465,635

14,465,635

137,802

1,210,150

1,210,150

587,802

Endorsement agreement, term

18 months

18 months

14 months

Endorsement agreement, advance

1,850,000

19,000,000

250,000

3,750,000

Vesting period

12 months

3 years

3 years

Term of award, years

5

5

5

Shares issued for services

4,000

11,167

604,406

Warrants issued, number of shares of common stock

250,000

133,334

66,667

133,333

66,667

133,333

133,333

333,333

200,000

Warrants to purchase common stock, exercise price per share

$5.70

$7.05

$7.05

$7.05

$7.05

$6.90

$7.36

$5.85

Shares issued for services, expense

24,000

67,000

150,674

454,723

80,677

366,949

81,695

Total expense to be incurred over the life of the contract

$250,000

Stockholders_equity_Narrative_

Stockholders' equity (Narrative) (Details) (USD $)	3 Months Ended	6 Months Ended
	Mar. 31, 2013	Mar. 31, 2013	Mar. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding	10,387,864	10,387,864
Stock-based compensation expense	2,501,729	5,499,232
Weighted average remaining contractual term		42 months 27 days
Unrecognized compensation expense	9,084,508	9,084,508
2007 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares authorized for issuance	266,667	266,667
2011 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares authorized for issuance	1,666,667	1,666,667
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares authorized for issuance	3,000,000	3,000,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding	1,805,000	1,805,000
Vested	1,160,555	1,160,555
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding	3,905,992	3,905,992
Vested	2,351,970	2,351,970
Grants in period	200,000	486,667	1,003,000
Expirations		26,667
Warrants [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period		133,333
Exercise price per share		6.9
Term of award, years		5
Warrants [Member] | Kim Petry [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period		200,000
Exercise price per share		5.85
Term of award, years		5
Warrants [Member] | Mr. Isaac Blech [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price per share			166,667
Exercised			7.65
Term of award, years			5
Warrants [Member] | Mr. Desantis [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period			666,667
Exercise price per share			6
Term of award, years			5
Warrants [Member] | Mr. Proto [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period			3,000,000
Exercise price per share			6.6
Term of award, years			5
Warrants [Member] | Advisors, Consultants, Intellectual Property Purchases [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period		20,000
Warrants [Member] | Investors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding	4,676,872	4,676,872
Grants in period		4,717,276

Stockholders_equity_Summary_of

Stockholders' equity (Summary of Options and Warrants Outstanding) (Details) (USD $)	Mar. 31, 2013
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	10,387,864
3rd Qtr, 2013 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	19,667
Weighted Average Exercise Price	9.3
4th Qtr, 2013 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	124,000
Weighted Average Exercise Price	7.2
1st Qtr, 2014 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	134,445
Weighted Average Exercise Price	6.6
2nd Qtr, 2014 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	42,044
Weighted Average Exercise Price	8.25
3rd Qtr, 2014 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	60,667
Weighted Average Exercise Price	9.6
4th Qtr, 2014 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	35,000
Weighted Average Exercise Price	7.65
1st Qtr, 2015 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	106,973
Weighted Average Exercise Price	7.65
2nd Qtr, 2015 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	78,100
Weighted Average Exercise Price	7.8
3rd Qtr, 2015 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	10,600
Weighted Average Exercise Price	10.05
4th Qtr, 2015 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	103,918
Weighted Average Exercise Price	6.75
1st Qtr, 2016 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	695,572
Weighted Average Exercise Price	8.1
2nd Qtr, 2016 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	882,800
Weighted Average Exercise Price	7.2
3rd Qtr, 2016 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	960,100
Weighted Average Exercise Price	6.45
4th Qtr, 2016 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	1,239,958
Weighted Average Exercise Price	6.75
1st Qtr, 2017 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	697,996
Weighted Average Exercise Price	7.95
2nd Qtr, 2017 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	859,750
Weighted Average Exercise Price	6.15
3rd Qtr, 2017 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	1,273,600
Weighted Average Exercise Price	7.8
4th Qtr, 2017 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	1,992,958
Weighted Average Exercise Price	6.75
1st Qtr, 2018 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	736,383
Weighted Average Exercise Price	7.95
2nd Qtr, 2018 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	210,000
Weighted Average Exercise Price	5.85
1st Qtr, 2023 [Member]
Share Based Payment Award, By Expiration Fiscal Period [Line Items]
Outstanding	124,000
Weighted Average Exercise Price	7.2

Stockholders_equity_Schedule_o

Stockholders' equity (Schedule of Assumptions for Calculations of Newly Issued Options and Warrants) (Details)	6 Months Ended
	Mar. 31, 2013
Stockholders' equity [Abstract]
Expected life (in years)	4 years 3 months 29 days
Weighted average volatility	93.89%
Forfeiture rate	0.00%
Risk-free interest rate	0.74%
Expected dividend rate	0.00%

Income_taxes_Details

Income taxes (Details) (USD $)	Mar. 31, 2013	Sep. 30, 2012
Income taxes [Abstract]
Net operating loss carry forward	$56,027,000	$31,000,000
Deferred tax asset	$22,579,000	$12,885,000

Subsequent_events_Details

Subsequent events (Details) (USD $)	Mar. 31, 2013	Sep. 30, 2012	Mar. 31, 2012	Jun. 10, 2013	Oct. 01, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013	Jun. 10, 2013
				Warrant Holder Amendment [Member]	Board of Directors [Member]	Warrants One [Member]	Warrants Two [Member]	Warrants Three [Member]	Warrants Four [Member]	Warrants Five [Member]	Warrants Six [Member]	Warrants Seven [Member]	Warrants Eight [Member]	Private Placement One [Member]	Private Placement Two [Member]	Private Placement Three [Member]	Private Placement Four [Member]
Subsequent Event [Line Items]
Common stock, shares issued	9,261,062	5,855,313
Common stock, shares outstanding	9,261,062	5,855,313
Common stock, par value	$0.00	$0.00
Exercise price per share				$2.25	$2	$7.50	$9	$7.50	$9	$7.50	$9	$6	$9
Warrants issued, number of shares of common stock					133,333	541,667	93,249	833,333	183,185	333,334	112,854	125,000	306,950	634,916	1,016,518	446,188	431,950
Warrants	$14,465,635		$137,802
Proceeds from issuance of equity, net				$1,490,715
Conversion, preferred shares converted				662,540			85,974	83,334	99,703	93,751	82,408	62,500	154,879